Clarvisan

Clarvisan Medicine

Top 20 drugs with the same components:

Incompatibilities

It is not recommended to use simultaneously with eye drops containing metal ions (silver solutions, collargol, zinc sulfate), because Clarvisan changes color in their presence.

Pharmaceutical form

Coated tablets

Undesirable effects

It is possible to develop superficial keratitis, blepharitis, redness of the conjunctiva, a burning sensation or itching after instilling the drug.

Therapeutic indications

The initial stages of senile cataracts.

Pharmacotherapeutic group

  • Cataract Treatment [Ophthalmic Remedies]

Pharmacodynamic properties

Pyrenoxine competitively inhibits the action of quinone substances produced as a result of abnormal metabolism of aromatic amino acids and stimulating the conversion of water-soluble protein in the lens to insoluble, resulting in the substance of the lens becomes cloudy. By inhibiting the action inanovich substances, pirenoxine prevents the development of cataracts.

Name of the medicinal product

Clarvisan

Qualitative and quantitative composition

Pirenoxine

Dosage (Posology) and method of administration

Conjunctivally. Immediately before use, dissolve 1 tablet in 15 ml of solvent and instill in the conjunctival sac 1-2 drops of the solution 3-5 times a day.